WAINUA
Active substance: eplontersen
INJECTION, SOLUTION · EPLONTERSEN 45 mg/.8mL
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- EPLONTERSEN · 45 mg/.8mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-ac0d-73cd-8202-4b25da19bf65,01a1209b-8b58-72de-88de-fca7c7927729;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0310-9420
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0310-9420 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-9420 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-9420 · Verified 2026-10-09 · open in source